Complete nucleotide sequence of a plasmid containing the botulinum neurotoxin gene in Clostridiumbotulinum type B strain 111 isolated from an infant patient in Japan
暂无分享,去创建一个
Y. Sakaguchi | D. Motooka | T. Iida | Kazuyoshi Gotoh | S. Kozaki | M. Mukamoto | T. Kohda | Kaoru Umeda | Koji Hosomi | S. Nakamura
[1] Gary Xie,et al. Molecular characterization of a novel botulinum neurotoxin type H gene. , 2014, The Journal of infectious diseases.
[2] S. Arnon,et al. A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins. , 2014, The Journal of infectious diseases.
[3] S. Kozaki,et al. Multi-locus variable number tandem repeat analysis for Clostridium botulinum type B isolates in Japan: comparison with other isolates and genotyping methods. , 2013, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[4] Y. Seto,et al. Stability of toxigenicity in proteolytic Clostridium botulinum type B upon serial passage , 2012, Microbiology and immunology.
[5] Leonard A. Smith,et al. Recombination and insertion events involving the botulinum neurotoxin complex genes in Clostridium botulinum types A, B, E and F and Clostridium butyricum type E strains , 2009, BMC Biology.
[6] Y. Fujinaga,et al. A novel function of botulinum toxin-associated proteins: HA proteins disrupt intestinal epithelial barrier to increase toxin absorption. , 2009, Toxicon : official journal of the International Society on Toxinology.
[7] Y. Seto,et al. Genetic Characterization of Clostridium botulinum Associated with Type B Infant Botulism in Japan , 2009, Journal of Clinical Microbiology.
[8] Yuji Nagata,et al. GenomeMatcher: A graphical user interface for DNA sequence comparison , 2008, BMC Bioinformatics.
[9] Leonard A. Smith,et al. Analysis of the Neurotoxin Complex Genes in Clostridium botulinum A1-A4 and B1 Strains: BoNT/A3, /Ba4 and /B1 Clusters Are Located within Plasmids , 2007, PloS one.
[10] W. Lencer,et al. The HA proteins of botulinum toxin disrupt intestinal epithelial intercellular junctions to increase toxin absorption , 2007, Cellular microbiology.
[11] A. T. Carter,et al. Genome sequence of a proteolytic (Group I) Clostridium botulinum strain Hall A and comparative analysis of the clostridial genomes. , 2007, Genome research.
[12] S. Kozaki,et al. Differential contribution of the residues in C-terminal half of the heavy chain of botulinum neurotoxin type B to its binding to the ganglioside GT1b and the synaptotagmin 2/GT1b complex. , 2007, Microbial pathogenesis.
[13] M. Hattori,et al. The genome sequence of Clostridium botulinum type C neurotoxin-converting phage and the molecular mechanisms of unstable lysogeny. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[14] C. Keet,et al. Recent advances in infant botulism. , 2005, Pediatric neurology.
[15] Jizhong Zhou,et al. Alkaline Anaerobic Respiration: Isolation and Characterization of a Novel Alkaliphilic and Metal-Reducing Bacterium , 2004, Applied and Environmental Microbiology.
[16] B. Dupuy,et al. Organization and regulation of the neurotoxin genes in Clostridium botulinum and Clostridium tetani. , 2004, Anaerobe.
[17] T. Karasawa,et al. Sequence of the gene for Clostridium botulinum type B neurotoxin associated with infant botulism, expression of the C-terminal half of heavy chain and its binding activity. , 2003, Biochimica et biophysica acta.
[18] M. Waldor,et al. Filamentous phage integration requires the host recombinases XerC and XerD , 2002, Nature.
[19] Philip K. Russell,et al. Botulinum toxin as a biological weapon: medical and public health management. , 2001, JAMA.
[20] H. Niki,et al. Active segregation by the Bacillus subtilis partitioning system in Escherichia coli. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[21] H. Mori,et al. The R‐type pyocin of Pseudomonas aeruginosa is related to P2 phage, and the F‐type is related to lambda phage , 2000, Molecular microbiology.
[22] T. Karasawa,et al. Characterization of Clostridium botulinum Type B Neurotoxin Associated with Infant Botulism in Japan , 1998, Infection and Immunity.
[23] H. Korkeala,et al. Genomic Analysis of Clostridium botulinum Group II by Pulsed-Field Gel Electrophoresis , 1998, Applied and Environmental Microbiology.
[24] S. Nakamura,et al. Emergence of Clostridium botulinum type B-like nontoxigenic organisms in a patient with type B infant botulism , 1997, Journal of clinical microbiology.
[25] B. Efron,et al. Bootstrap confidence levels for phylogenetic trees. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[26] B. Efron,et al. Bootstrap confidence levels for phylogenetic trees. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[27] K. Yamakawa,et al. The first case of type B infant botulism in Japan , 1996, Acta paediatrica Japonica : Overseas edition.
[28] G. Schiavo,et al. Structure and function of tetanus and botulinum neurotoxins , 1995, Quarterly Reviews of Biophysics.
[29] F. Cornet,et al. Plasmid pSC101 harbors a recombination site, psi, which is able to resolve plasmid multimers and to substitute for the analogous chromosomal Escherichia coli site dif , 1994, Journal of bacteriology.
[30] C. Hatheway,et al. Toxigenic clostridia , 1990, Clinical Microbiology Reviews.
[31] H. Sugiyama. Clostridium botulinum neurotoxin. , 1980, Microbiological reviews.
[32] J. Blake,et al. Case of infant botulism in Texas. , 1977, Texas medicine.
[33] C. A. Smith,et al. Bacteriophage and the Toxigenicity of Clostridium botulinum Type C , 1971, Science.
[34] C. Lamanna,et al. The Isolation of Type B Botulinum Toxin , 1947, Journal of bacteriology.
[35] K. Hill,et al. Genetic diversity within Clostridium botulinum serotypes, botulinum neurotoxin gene clusters and toxin subtypes. , 2013, Current topics in microbiology and immunology.
[36] B. Das,et al. Integrative mobile elements exploiting Xer recombination. , 2013, Trends in microbiology.
[37] M. Peck. Biology and genomic analysis of Clostridium botulinum. , 2009, Advances in microbial physiology.
[38] U. Zielenkiewicz,et al. Mechanisms of plasmid stable maintenance with special focus on plasmid addiction systems. , 2001, Acta biochimica Polonica.
[39] D. Ladant,et al. The comprehensive sourcebook of bacterial protein toxins , 1999 .
[40] M. Chandler,et al. Insertion Sequences , 1998, Microbiology and Molecular Biology Reviews.